The Impact of Patient and Lesion Complexity on Clinical and Angiographic Outcomes After Revascularization With Zotarolimus- and Everolimus-Eluting Stents: A Substudy of the RESOLUTE All Comers Trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention)
- 31 May 2011
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 57 (22), 2221-2232
- https://doi.org/10.1016/j.jacc.2011.01.036
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary StentsThe New England Journal of Medicine, 2010
- Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificityEuroIntervention, 2010
- Safety and Efficacy of Drug-Eluting and Bare Metal StentsCirculation, 2009
- Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery DiseaseThe New England Journal of Medicine, 2009
- Incidence and Correlates of Drug-Eluting Stent Thrombosis in Routine Clinical Practice: 4-Year Results From a Large 2-Institutional Cohort StudyJournal of the American College of Cardiology, 2008
- Impact of “Off-Label” Utilization of Drug-Eluting Stents on Clinical Outcomes in Patients Undergoing Percutaneous Coronary InterventionThe American Journal of Cardiology, 2008
- A Comparison of Bare-Metal and Drug-Eluting Stents for Off-Label IndicationsThe New England Journal of Medicine, 2008
- Clinical End Points in Coronary Stent TrialsCirculation, 2007
- Sirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary RevascularizationThe New England Journal of Medicine, 2005
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryThe New England Journal of Medicine, 2003